RESUMO
Gut microbiota plays a crucial role in inflammatory bowel diseases (IBD) and can potentially prevent IBD through microbial-derived metabolites, making it a promising therapeutic avenue. Recent evidence suggests that despite an unclear underlying mechanism, red cabbage juice (RCJ) alleviates Dextran Sodium Sulfate (DSS)-induced colitis in mice. Thus, the study aims to unravel the molecular mechanism by which RCJ modulates the gut microbiota to alleviate DSS-induced colitis in mice. Using C57BL/6J mice, we evaluated RCJ's protective role in DSS-induced colitis through two cycles of 3% DSS. Mice were daily gavaged with PBS or RCJ until the endpoint, and gut microbiota composition was analyzed via shotgun metagenomics. RCJ treatment significantly improved body weight (p ≤ 0.001), survival in mice (p < 0.001) and reduced disease activity index (DAI) scores. Further, RCJ improved colonic barrier integrity by enhancing the expression of protective colonic mucins (p < 0.001) and tight junction proteins (p ≤ 0.01) in RCJ + DSS-treated mice compared to the DSS group. Shotgun metagenomic analysis revealed an enrichment of short-chain fatty acids (SCFAs)-producing bacteria (p < 0.05), leading to increased Peroxisome Proliferator-Activated Receptor Gamma (PPAR-γ) activation (p ≤ 0.001). This, in turn, resulted in repression of the nuclear factor κB (NFκB) signaling pathway, causing decreased production of inflammatory cytokines and chemokines. Our study demonstrates colitis remission in a DSS-induced mouse model, showcasing RCJ as a potential modulator for gut microbiota and metabolites, with promising implications for IBD prevention and treatment.
Assuntos
Colite , Microbioma Gastrointestinal , Doenças Inflamatórias Intestinais , Animais , Camundongos , Camundongos Endogâmicos C57BL , Colite/induzido quimicamente , HomeostaseRESUMO
OBJECTIVE: To report the locoregional anesthesia and analgesia preferences of veterinary anesthesiologists for use in dogs undergoing a TPLO and determine any association with specialty college, time from board-certification, or employment sector. STUDY DESIGN: Cross sectional study. SAMPLE POPULATION: Diplomates of the American (ACVAA) and European (ECVAA) Colleges of Veterinary Anesthesia and Analgesia. METHODS: An electronic survey was distributed to diplomates and responses were used to determine associations between preferred methods. RESULTS: The survey response rate was 28% (141/500) with 69% (97/141) of ACVAA diplomates and 31% of diplomates with ECVAA (44/141) certification. Peripheral nerve block (PNB) was preferred by 79% (111/141) of all diplomates, lumbosacral epidural (LE) by 21% (29/141), and peri-incisional infiltration (PI) by <1% (1/141). There was no association (p = .283) with specialty college. There was an association (p < .001) with time from board-certification with increased preference for LE when >10-years from certification and PI preferred by only those board-certified >20-years ago. There was an association with employment sector (p = .003) with more academic diplomates preferring LE. Anesthesiologists reported that treatment decisions were affected by various factors including time pressure and surgeon influence. CONCLUSION: Diplomates of ACVAA and ECVAA prefer PNB as the locoregional method of pelvic limb anesthesia in dogs undergoing TPLO. A greater percentage of newer and private practice diplomates prefer PNB while a larger percentage of senior and academic diplomates prefer LE. Decision making is multifactorial and includes perceived time pressure and surgeon influence. CLINICAL SIGNIFICANCE: Veterinary anesthesiologists prefer and frequently use PNB in dogs undergoing TPLO and surgeon influence may affect their chosen treatment.
Assuntos
Analgesia , Anestesia , Anestesiologistas , Osteotomia , Tíbia , Animais , Cães , Humanos , Analgesia/métodos , Analgesia/veterinária , Anestesia/métodos , Anestesia/veterinária , Anestesiologistas/psicologia , Anestesiologistas/estatística & dados numéricos , Certificação , Estudos Transversais , Osteotomia/veterinária , Osteotomia/métodos , Tíbia/cirurgia , Estados Unidos , Inquéritos e Questionários , Europa (Continente) , Bloqueio Nervoso/métodos , Bloqueio Nervoso/veterinária , Nervos PeriféricosRESUMO
An abrupt balance impairment, including leaning, falling, and rolling, occurred after IV administration of 0.2 mg/kg midazolam as a preanesthetic medication in two geriatric dogs with a history of nystagmus and head tilt. In the second case, leaning, falling, and rolling recurred after recovery from general anesthesia but gradually ceased after IV administration of 0.01 mg/kg flumazenil. These two cases suggest that the IV administration of midazolam was responsible for the balance impairment in dogs who were suspected to have idiopathic peripheral vestibular disease.
Assuntos
Adjuvantes Anestésicos/efeitos adversos , Doenças do Cão/induzido quimicamente , Midazolam/efeitos adversos , Doenças Vestibulares/veterinária , Envelhecimento , Animais , Cães , Feminino , Masculino , Doenças Vestibulares/induzido quimicamenteRESUMO
OBJECTIVE: To determine the time of onset and duration of action of distal paravertebral blocks (DPB) in dairy cattle using lidocaine and lidocaine plus xylazine (LX). ANIMALS: 10 healthy adult Holstein cows. METHODS: Unilateral DPB were performed in 6 cows at L1, L2, and L4. They received 2 treatments (lidocaine and LX) in a blinded random crossover design. Due to treatment failure, 4 additional cows were enrolled. The lidocaine treatment received 1,800 mg (90 mL) of lidocaine, and treatment LX received 1,784 mg (89.2 mL) of lidocaine and 16 mg (0.8 mL) of xylazine. Anesthesia was assessed by response (rapid movements of the tail, directed movements of the feet, or turning of the head towards the site of the needle pricks) to 6 approximately 1-cm deep needle pricks to the paralumbar fossa with a 22-gauge hypodermic needle. The time of onset, duration of action, maximum sedation score, and average heart rate (HR) were compared between treatments. RESULTS: Duration of anesthesia was significantly prolonged after DPB in cows treated with LX (251.6 ± 96.94 minutes) compared to lidocaine (105.8 ± 35.9 minutes; P = .01). Treatment with LX was associated with significantly lower average heart rate (56 ± 3 beats/min) compared to cows treated with lidocaine (59 ± 3 beats/min; P = .045). The LX treatment was associated with mild sedation but was not significant (P = .063). CLINICAL RELEVANCE: The addition of xylazine to a lidocaine DPB provides a longer duration of anesthesia, is inexpensive and practical, and can be implemented with ease.
Assuntos
Anestesia Epidural , Bloqueio Nervoso , Animais , Bovinos , Feminino , Anestesia Epidural/veterinária , Anestésicos Locais/farmacologia , Lidocaína/farmacologia , Bloqueio Nervoso/veterinária , Xilazina/farmacologiaRESUMO
Magnetic resonance imaging (MRI) is a well-established and widely used technique to characterize and quantify skeletal and cardiac muscle changes in Duchenne muscular dystrophy (DMD). Recently, MRI has been explored to study disease progression and response to gene therapy in the canine DMD model. Using traditional sequences, delayed gadolinium enhancement, novel sequences, and spectroscopy, investigators have begun to (i) establish the baseline MRI characteristics of the muscles in normal and affected dogs and (ii) evaluate gene therapy outcomes in treated dogs. As a noninvasive assay, MRI offers an excellent opportunity to study longitudinal muscle changes in long-term gene therapy studies in the canine model. In this chapter, we outline the MRI method used to study DMD in the canine model.
Assuntos
Distrofia Muscular de Duchenne , Cães , Animais , Distrofia Muscular de Duchenne/diagnóstico por imagem , Distrofia Muscular de Duchenne/genética , Distrofia Muscular de Duchenne/terapia , Meios de Contraste , Músculo Esquelético/patologia , Gadolínio , Imageamento por Ressonância Magnética/métodos , Terapia GenéticaRESUMO
Gut microbiota plays a crucial role in inflammatory bowel disease (IBD) and has therapeutic benefits. Thus, targeting the gut microbiota is a promising therapeutic approach for IBD treatment. We recently found that red cabbage juice (RCJ) ameliorates dextran sulfate sodium (DSS)-induced colitis in mice. However, the underlying mechanisms remain unknown. The current study investigated the modulation of gut microbiota in response to treatment with RCJ to ameliorate the DSS colitis. The initial results demonstrated that mice treated with DSS + RCJ showed increased body weight and decreased diarrhea and blood in feces compared to the DSS alone group. RCJ ameliorated colitis by regulating the intestinal barrier function by reducing the number of apoptotic cells, improving colonic protective mucin, and increasing tight junction protein in RCJ + DSS groups compared to the DSS group. Short-gun metagenomic analysis revealed significant enrichment of short-chain fatty acid (SCFAs)-producing bacteria (Butyrivibrio, Ruminococcaceae, Acetatifactor muris, Rosburia Sp. CAG:303 , Dorea Sp. 5-2) increased PPAR-© activation, leading to repression of the nuclear factor κB (NFκB) signaling pathway, thus decreasing the production of crucial inflammatory cytokines and chemokines in the RCJ + DSS groups compared to the DSS group. Pathway abundance analysis showed an increased abundance of the SCFA pathway, reduced histidine degradation ( Bacteroides sartorii, and Bacteroides caecimuris ), and LCFA production in the RCJ+DSS treated group, suggesting the promotion of good colonic health. Furthermore, increased T-reg (FOXP3+) cells in the colon were due to SCFAs produced by the gut microbiota, which was corroborated by an increase in IL-10, a vital anti-inflammatory cytokine. Thus, our study provides the first evidence that RCJ ameliorates colonic inflammation by modulating the gut microbiota.
RESUMO
OBJECTIVE: To assess the intraoperative and postoperative clinical effects and histologic effects of intracameral administration of α-chymotrypsin in clinically normal dogs undergoing standard intracapsular lens extraction (ICLE). ANIMALS: 6 young adult male dogs without evidence of systemic or ocular disease. PROCEDURES: All dogs underwent bilateral ICLE 7 minutes following injection of 75 U of α-chymotrypsin or an identical volume (0.5 mL) of a commercially available balanced saline solution (BSS) into the posterior chamber of the eye. Ease of lens extraction was subjectively assessed and intraoperative intraocular hemorrhage and fibrin accumulation scored. For 27 days after surgery, ocular hyperemia and discharge, chemosis, corneal edema, hyphema, and aqueous flare were scored, and intraocular pressure (IOP) was measured. Thirty days after surgery, histologic evidence of anterior synechia, collapse of and inflammation within the iridocorneal angle, and iritis were scored. RESULTS: In 5 of 6 dogs, the surgeon was able to correctly identify the eye treated with α-chymotrypsin on the basis of ease of lens extraction. Mean intraoperative intraocular hemorrhage and fibrin scores for BSS-treated eyes were significantly higher than for α-chymotrypsin-treated eyes. Postoperatively, there were no significant differences between treatments for any clinical variables, including IOP Histologic scores were not significantly different between treatments for any variable. Vision was lost as a result of glaucoma in 1 α-chymotrypsin-treated eye and 1 BSS-treated eye. CONCLUSIONS AND CLINICAL RELEVANCE: Intracameral administration of 75 U of α-chymotrypsin 7 minutes before ICLE facilitated lensectomy without apparent adverse effects in clinically normal dogs.
Assuntos
Extração de Catarata/veterinária , Quimotripsina/farmacologia , Doenças do Cão/cirurgia , Animais , Câmara Anterior/efeitos dos fármacos , Câmara Anterior/cirurgia , Extração de Catarata/métodos , Quimotripsina/administração & dosagem , Edema da Córnea/epidemiologia , Edema da Córnea/veterinária , Cães , Eutanásia , Olho/patologia , Oftalmopatias/cirurgia , Oftalmopatias/veterinária , Glaucoma/cirurgia , Glaucoma/veterinária , Hiperemia/epidemiologia , Hiperemia/veterinária , Hifema/epidemiologia , Hifema/veterinária , Pressão Intraocular , Cápsula do Cristalino/efeitos dos fármacos , MasculinoRESUMO
Mild reduction in food intake was recently shown to slow polycystic kidney disease (PKD) progression in mouse models, but whether the effect was due to solely reduced calories or some other aspect of the diet has been unclear. We now show that the benefit is due to the induction of ketosis. Time-restricted feeding, without caloric reduction, strongly inhibits mTOR signaling, proliferation, and fibrosis in the affected kidneys in a PKD rat model. A ketogenic diet had a similar effect and led to regression of renal cystic burden. Acute fasting in rat, mouse, and feline models of PKD results in rapid reduction of cyst volume, while oral administration of the ketone ß-hydroxybutyrate (BHB) in rats strongly inhibits PKD progression. These results suggest that cystic cells in PKD are metabolically inflexible, which could be exploited by dietary interventions or supplementation with BHB, representing a new therapeutic avenue to treat PKD.
Assuntos
Cistos/dietoterapia , Dieta Cetogênica/métodos , Cetose/metabolismo , Doenças Renais Policísticas/dietoterapia , Ácido 3-Hidroxibutírico , Animais , Gatos , Cistos/metabolismo , Cistos/patologia , Modelos Animais de Doenças , Progressão da Doença , Jejum , Feminino , Fibrose , Rim/patologia , Masculino , Camundongos , Camundongos Endogâmicos C57BL , Doenças Renais Policísticas/metabolismo , Doenças Renais Policísticas/patologia , Ratos , Ratos Sprague-DawleyRESUMO
OBJECTIVE: To determine the effects of ketamine hydrochloride on hemodynamic and immunologic alterations associated with experimentally induced endotoxemia in dogs. ANIMALS: 9 mixed-breed dogs. PROCEDURES: In a crossover study, dogs were randomly allocated to receive ketamine (0.5 mg/kg, IV, followed by IV infusion at a rate of 0.12 mg/kg/h for 2.5 hours) or control solution (saline [0.9% NaCl] solution, 0.25 mL, IV, followed by IV infusion at a rate of 0.5 mL/h for 2.5 hours). Onset of infusion was time 0. At 30 minutes, lipopolysaccharide (LPS; 1 microg/kg, IV) was administered. Heart rate (HR), systolic arterial blood pressure (SAP), plasma tumor necrosis factor (TNF)-alpha activity, and a CBC were evaluated. RESULTS: Mean SAP was significantly reduced in dogs administered ketamine or saline solution at 2 and 2.5 hours, compared with values at time 0. However, there was no significant difference between treatments. At 1, 2, and 2.5 hours, dogs administered ketamine had a significantly lower HR than dogs administered saline solution. Although plasma TNF-alpha activity significantly increased, compared with values at time 0 for both groups, ketamine-treated dogs had significantly lower peak plasma TNF-alpha activity 1.5 hours after LPS administration. All dogs had significant leukopenia and neutropenia after LPS administration, with no differences detected between ketamine and saline solution treatments. CONCLUSIONS AND CLINICAL RELEVANCE: Administration of a subanesthetic dose of ketamine had immunomodulating effects in dogs with experimentally induced endotoxemia (namely, blunting of plasma TNF-alpha activity). However, it had little effect on hemodynamic stability and no effect on WBC counts.
Assuntos
Anestésicos/farmacologia , Pressão Sanguínea/efeitos dos fármacos , Endotoxemia/veterinária , Frequência Cardíaca/efeitos dos fármacos , Ketamina/farmacologia , Animais , Estudos Cross-Over , Cães , Relação Dose-Resposta a Droga , Endotoxemia/induzido quimicamente , Endotoxemia/tratamento farmacológico , Leucócitos/efeitos dos fármacos , Neutrófilos/efeitos dos fármacos , Fatores de Tempo , Fator de Necrose Tumoral alfa/metabolismoRESUMO
OBJECTIVE: To evaluate the clinical and immunologic response in healthy dogs to infusions of human serum albumin (HSA). ANIMALS: 9 healthy purpose-bred mixed-breed dogs. PROCEDURES: Each dog was administered a 25% HSA solution once or twice. Various physical examination and laboratory variables were serially evaluated. Antibody against HSA was assayed before and after infusion by use of an ELISA. Intradermal testing was also conducted. A repeated-measures ANOVA or Friedman repeated-measures ANOVA on ranks was used to compare results for the variables. RESULTS: Adverse clinical reactions were observed after the first or second infusion in 3 dogs. Anaphylactoid reactions were observed in 1 of 9 dogs during the first infusion and in 2 of 2 dogs administered a second infusion. Two dogs developed severe edema and urticaria 6 or 7 days after an initial infusion. All dogs developed anti-HSA antibodies. Positive responses for ID tests were observed in 8 of 9 dogs. Short-term increases were detected in blood protein, total bilirubin, and calcium concentrations after HSA infusion. Serum cholesterol concentrations and platelet counts decreased after HSA infusion. CONCLUSIONS AND CLINICAL RELEVANCE: Administration of HSA resulted in profound reactions in 2 of 9 dogs administered a single infusion and in 2 of 2 dogs administered a second infusion. This indicates that there is risk of life-threatening adverse reactions to HSA infusion in healthy dogs.
Assuntos
Doenças do Cão/induzido quimicamente , Edema/veterinária , Albumina Sérica/efeitos adversos , Urticária/veterinária , Animais , Doenças do Cão/imunologia , Cães , Edema/induzido quimicamente , Feminino , Saúde , Humanos , Masculino , Urticária/induzido quimicamenteRESUMO
OBJECTIVE: To assess the reliability and accuracy of a predictive rectal thermometer, an infrared auricular thermometer designed for veterinary use, and a subcutaneous temperature-sensing microchip for measurement of core body temperature over various temperature conditions in dogs. DESIGN: Prospective study. ANIMALS: 8 purpose-bred dogs. PROCEDURES: A minimum of 7 days prior to study commencement, a subcutaneous temperature-sensing microchip was implanted in 1 of 3 locations (interscapular, lateral aspect of shoulder, or sacral region) in each dog. For comparison with temperatures measured via rectal thermometer, infrared auricular thermometer, and microchip, core body temperature was measured via a thermistor-tipped pulmonary artery (TTPA) catheter. Hypothermia was induced during anesthesia at the time of TTPA catheter placement; on 3 occasions after placement of the catheter, hyperthermia was induced via administration of a low dose of endotoxin. Near-simultaneous duplicate temperature measurements were recorded from the TTPA catheter, the rectal thermometer, auricular thermometer, and subcutaneous microchips during hypothermia, euthermia, and hyperthermia. Reliability (variability) of temperature measurement for each device and agreement between each device measurement and core body temperature were assessed. RESULTS: Variability between duplicate near-simultaneous temperature measurements was greatest for the auricular thermometer and least for the TTPA catheter. Measurements obtained by use of the rectal thermometer were in closest agreement with core body temperature; for all other devices, temperature readings typically underestimated core body temperature. CONCLUSIONS AND CLINICAL RELEVANCE: Among the 3 methods of temperature measurement, rectal thermometry provided the most accurate estimation of core body temperature in dogs.
Assuntos
Temperatura Corporal/fisiologia , Cateterismo de Swan-Ganz/veterinária , Febre/veterinária , Hipotermia/veterinária , Artéria Pulmonar/fisiologia , Termômetros/veterinária , Animais , Cateterismo de Swan-Ganz/métodos , Estudos Cross-Over , Cães , Orelha , Feminino , Febre/diagnóstico , Hipotermia/diagnóstico , Masculino , Procedimentos Analíticos em Microchip/veterinária , Estudos Prospectivos , Reto , Sensibilidade e Especificidade , Termômetros/normasRESUMO
OBJECTIVES: Feline allergic asthma is a common chronic lower airway disease characterized by clinical signs attributed to eosinophilic inflammation, airway hyper-responsiveness (AHR) and airway remodeling. Tachykinins released from sensory nerves and immune cells bind neurokinin-1 (NK-1) receptors in the lung. The resultant neurogenic airway inflammation has been implicated in asthma pathogenesis. In mouse models and spontaneous human asthma, NK receptor antagonists reduce bronchospasm and inflammation. We hypothesized that chronic administration of maropitant, an NK-1 receptor antagonist, would decrease clinical signs of asthma, AHR and eosinophilic inflammation in experimentally asthmatic cats. METHODS: Cats (n = 6) induced to have asthma using Bermuda grass allergen (BGA) were enrolled in a randomized, prospective, placebo-controlled crossover design study. Cats received either oral maropitant (2 mg/kg) or placebo q48h for 4 weeks; following a 2 week washout, cats were crossed-over to the alternate treatment. Study endpoints included subjective clinical scoring systems after BGA challenge, ventilator-acquired pulmonary mechanics to assess AHR after bronchoprovocation with methacholine, and collection of bronchoalveolar lavage fluid to quantify airway eosinophilia. Statistical analysis was performed using a Mann-Whitney rank sum test with P <0.05 considered significant. RESULTS: Administration of maropitant for 1 month in experimentally asthmatic cats produced no significant difference in clinical scoring scheme (P = 0.589 and P = 1.0), AHR (P = 0.818) or airway eosinophilia (P = 0.669) compared with placebo. CONCLUSIONS AND RELEVANCE: Chronic administration of maropitant was ineffective at blunting clinical signs, AHR and airway eosinophilia in experimental feline asthma and thus cannot be recommended as a novel treatment for this disorder.
Assuntos
Asma/veterinária , Doenças do Gato/tratamento farmacológico , Eosinofilia/veterinária , Antagonistas dos Receptores de Neurocinina-1 , Receptores da Neurocinina-1 , Alérgenos/imunologia , Animais , Asma/tratamento farmacológico , Líquido da Lavagem Broncoalveolar , Gatos , Modelos Animais de Doenças , Cloreto de Metacolina/administração & dosagem , Estudos Prospectivos , Distribuição AleatóriaRESUMO
OBJECTIVES: Feline allergic asthma is a chronic inflammatory disorder of the lower airways that may manifest with acute, life-threatening clinical signs. Tachykinins released from sensory nerves and immune cells binding neurokinin (NK)-1, NK-2 and NK-3 receptors have been implicated in asthma pathogenesis. Maropitant, an NK-1 receptor antagonist, blocks neuroimmune pathways and may be a viable treatment option for cats in asthmatic crisis. Using an experimental chronic allergic feline asthma model, we hypothesized that a single dose of maropitant given immediately after allergen challenge would blunt clinical signs, airway hyperresponsiveness (AHR) and airway eosinophilia. METHODS: Cats (n = 7) induced to have an asthmatic phenotype using Bermuda grass allergen (BGA) were enrolled in a prospective, placebo-controlled crossover design study. Cats randomly received maropitant (2 mg/kg SC) or placebo (saline SC) immediately post-BGA challenge, followed 12 h later by pulmonary mechanics testing and measurement of airway eosinophils. After a 2 week washout, cats were crossed-over to the alternate treatment. Study endpoints included subjective clinical scoring systems post-BGA challenge, ventilator-acquired pulmonary mechanics to assess AHR after bronchoprovocation with methacholine and collection of bronchoalveolar lavage fluid to quantify airway eosinophilia. Data were analyzed using a Mann-Whitney rank sum test with P <0.05 considered significant. RESULTS: A single injection of maropitant failed to diminish clinical composite score (P = 0.902), visual analogue scale scoring (P = 0.710), AHR (P = 0.456) or airway eosinophilia (P = 0.165) compared with placebo. CONCLUSIONS AND RELEVANCE: A single injection of maropitant given immediately post-allergen challenge was ineffective at blunting clinical signs, AHR and airway eosinophilia, and cannot be recommended as treatment for feline status asthmaticus.
Assuntos
Asma/veterinária , Doenças do Gato/imunologia , Eosinofilia/veterinária , Imunoterapia Ativa/veterinária , Quinuclidinas/administração & dosagem , Animais , Asma/induzido quimicamente , Asma/tratamento farmacológico , Asma/imunologia , Doenças do Gato/induzido quimicamente , Doenças do Gato/tratamento farmacológico , Gatos , Estudos Cross-Over , Modelos Animais de Doenças , Eosinofilia/tratamento farmacológico , Imunoterapia Ativa/métodos , Estudos Prospectivos , Receptores da Neurocinina-1/efeitos dos fármacosRESUMO
OBJECTIVES: The aim of this study was to evaluate the feasibility and efficacy of serially administered adipose-derived mesenchymal stem cells (MSCs) in an experimental feline asthma model. METHODS: Allergic asthma was acutely induced with Bermuda grass allergen in six purpose-bred cats. Five intravenous infusions of allogeneic MSCs (n = 4; MSC-treated) or saline (n = 2; placebo-treated) were administered over the first 130 days after asthma induction. Infusions contained 2 × 106, 4 × 106, 4.7 × 106, 1 × 107 and 1 × 107 cryopreserved MSCs/cat. For thoracic imaging additional cats were enrolled as control groups: four untreated, experimentally asthmatic cats (combined with placebo-treated cats), and six healthy, non-asthmatic cats. Outcome measures included airway eosinophilia, pulmonary mechanics, thoracic computed tomography and several immunologic assays. RESULTS: Cats were assessed for 9 months after treatment. At early points, airway eosinophil percentage was not affected by MSC administration (post-treatment average of days 12, 26, 47, 108 and 133 in MSC-treated cats was 41 ± 15% and in placebo-treated cats it was 34 ± 16%). By month 9, eosinophil percentages in all MSC-treated cats decreased to normal reference intervals (MSC-treated 6%; placebo-treated 20%; normal <17%). Diminished airway hyper-responsiveness was noted in all MSC-treated compared with placebo-treated cats at day 133 (dose of methacholine to double baseline airway resistance: MSC-treated median 22.9 mg/ml [range 6.4-64.0]; individual placebo-treated cats 1.1 and 5.0 mg/ml). Lung attenuation (mean ± SEM MSC-treated -865 ± 12 Hounsfield units [HU]; untreated asthmatics -820 ± 11 HU; P = 0.004) and bronchial wall thickening scores (median [interquartile range] MSC-treated 0 [0-1.5]; untreated asthmatic 11.6 [7.3-27.3]; P = 0.010) were significantly reduced in MSC-treated vs untreated asthmatic cats, consistent with decreased airway remodeling at month 9. No clear immunologic mechanisms by which MSCs act were determined. CONCLUSIONS AND RELEVANCE: MSCs may have a delayed effect in reducing airway inflammation, airway hyper-responsiveness and remodeling in experimentally induced asthmatic cats. Results warrant additional investigation of MSC therapy for asthma in cats.
Assuntos
Tecido Adiposo , Asma/veterinária , Doenças do Gato/tratamento farmacológico , Células-Tronco Mesenquimais , Alérgenos/imunologia , Animais , Asma/tratamento farmacológico , Doenças do Gato/diagnóstico por imagem , Doenças do Gato/etiologia , Gatos , Feminino , Infusões Intravenosas/veterinária , Masculino , Projetos Piloto , Testes de Função Respiratória/veterinária , Tomografia Computadorizada por Raios X/veterinária , Resultado do TratamentoRESUMO
OBJECTIVES: Airway hyper-responsiveness (AHR), a key feature of feline asthma, can be measured using bronchoprovocation testing. Limitations of both direct and indirect bronchoprovocants evaluated to date in experimental feline asthma have led to a search for a more specific indirect bronchoprovocant (ie, one which relies on existing inflammatory cells or activated neural pathways in diseased but not healthy airways). We hypothesized that capsaicin, a transient receptor potential cation channel subfamily V member 1 agonist, would lead to dose-responsive increases in airway resistance as measured by ventilator-acquired pulmonary mechanics in experimentally asthmatic cats. METHODS: Five cats induced to have asthma using Bermuda grass allergen (BGA) were studied. Twenty-four hours after aerosol challenge of BGA, cats were anesthetized and underwent neuromuscular blockade for ventilator-acquired pulmonary mechanics. Cats were monitored with pulse oximetry for hemoglobin desaturation. Parameters recorded on a breath-by-breath basis on the ventilator included airway resistance (Raw) and compliance. Saline at baseline and 10-fold increasing concentrations of capsaicin (0.4-4000.0 µM) were aerosolized for 30 s and data collected for 4 mins between doses. The intended endpoint of the study was a doubling in baseline airway resistance, halving of compliance or oxygen desaturation <75%. RESULTS: All cats completed the trial, reaching the highest dose of capsaicin without reaching any of the aforementioned endpoints. No biologically significant alteration in any other pulmonary mechanics parameter was noted. CONCLUSIONS AND RELEVANCE: Capsaicin does not appear to be an effective bronchoprovocant in a feline asthma model.
Assuntos
Asma/veterinária , Testes de Provocação Brônquica/veterinária , Capsaicina/metabolismo , Doenças do Gato/diagnóstico , Doenças do Gato/imunologia , Canais de Cátion TRPV/metabolismo , Resistência das Vias Respiratórias/efeitos dos fármacos , Alérgenos/imunologia , Animais , Gatos , Cynodon , Modelos AnimaisRESUMO
Opioids have immunomodulatory properties in many species, but there is little information pertaining to these properties in dogs. Our objective was to compare the in vivo effects of morphine, buprenorphine, and control solution on innate immune system function and apoptosis in healthy dogs. Six adult dogs received a 24-hour infusion of morphine, buprenorphine, or control solution (saline) in a randomized, controlled, crossover block design. Leukocyte apoptosis, phagocytosis, and oxidative burst were evaluated using flow cytometry. Lipopolysaccharide, lipoteichoic acid, and peptidoglycan-stimulated leukocyte production of tumor necrosis factor (TNF)-α, interleukin (IL)-6, and IL-10 were determined using canine specific multiplex assays. No significant treatment effects were detected among groups. These data suggest that healthy dogs could be less sensitive to the immunomodulatory effects of acute opioid administration compared with other species. Larger investigations in healthy and immunologically challenged dogs are recommended prior to application of these results in clinical patients.
Assuntos
Apoptose/efeitos dos fármacos , Buprenorfina/farmacologia , Citocinas/metabolismo , Leucócitos/metabolismo , Morfina/farmacologia , Neutrófilos/fisiologia , Fagocitose/efeitos dos fármacos , Analgésicos Opioides/farmacologia , Animais , Estudos Cross-Over , Cães , Feminino , Imunidade Inata/efeitos dos fármacos , Imunidade Inata/fisiologia , Interleucina-10/metabolismo , Interleucina-6/metabolismo , Leucócitos/efeitos dos fármacos , Lipopolissacarídeos/farmacologia , Masculino , Neutrófilos/efeitos dos fármacos , Peptidoglicano/farmacologia , Fagocitose/fisiologia , Ácidos Teicoicos/farmacologia , Fator de Necrose Tumoral alfa/metabolismoRESUMO
STUDY DESIGN: Prospective porcine animal model. OBJECTIVE: Determine if injecting FloSeal into pedicles for hemostasis causes emboli. SUMMARY OF BACKGROUND DATA: Bleeding from spinal deformity cases can be substantial, especially when surgical procedures involve bilateral fixation at multiple segments. It is not unusual to observe hemorrhage from vascular pedicles during each step of pedicle screw tract preparation. When multiple fixation points are required, blood loss can be excessive. To minimize estimated blood loss and associated morbidity, surgeons have injected liquefied gelatin into pedicles after drilling, palpating, and/or tapping. FloSeal is one of the most popular commercially available injectable agents and we sought to investigate the potential for embolization when used as an intrapedicular hemostatic agent. METHODS: Two adult minipigs were anesthetized and underwent sequential bilateral pedicle cannulation from T-spine to sacrum. At every level, tracts were cannulated, palpated, and tapped. In every tract, FloSeal was injected into each pedicle until back pressure was detected on the syringe or to a maximum volume of 2 mL, then pedicle screws were inserted. The right ventricular outflow tract was visualized real time using transesophageal echocardiography. Postmortem evaluation of heart and lungs was performed. RESULTS: FloSeal injected into pedicles caused a consistent large showering of the right ventricular outflow tract in both pigs as visualized on intraoperative transesophageal echocardiography. A second large showering occurred during screw insertion after FloSeal was injected. Microscopic examination of lungs clearly identified amphophilic amorphous material in many small vessels consistent with FloSeal. CONCLUSION: This study suggests caution when injecting gelatin hemostatic agents into pedicles to stop bleeding during spinal surgery as we saw clear evidence of fat and gelatin emboli when used in this animal model. Further investigation into how to minimize this embolic showering may help the cardiopulmonary at risk patient who requires spinal surgery, especially when multiple points of pedicle screw fixation are used. LEVEL OF EVIDENCE: N/A.
Assuntos
Perda Sanguínea Cirúrgica/prevenção & controle , Extravasamento de Materiais Terapêuticos e Diagnósticos/etiologia , Gelatina/efeitos adversos , Hemostáticos/efeitos adversos , Procedimentos Ortopédicos/métodos , Fusão Vertebral/métodos , Animais , Gelatina/uso terapêutico , Hemostáticos/uso terapêutico , Estudos Prospectivos , SuínosRESUMO
OBJECTIVE: To determine effects of selegiline hydrochloride, phenylpropanolamine (PPA), or a combination of both on physiologic and behavioral variables in dogs. ANIMALS: 40 adult hound-type dogs. PROCEDURE: Dogs were assigned to 4 groups. One group received selegiline (1 mg/kg, PO, q 24 h) and PPA (1.1 mg/kg, PO, q 8 h), a second group received selegiline alone, a third group received PPA alone, and a fourth group received neither drug. Dogs were observed 3 times/d throughout the 30-day study (daily during the first week, on alternate days during the next 2 weeks, and again daily during the final week). Observers recorded rectal temperature, pulse, respiratory rate, oscillometric blood pressure, and lead-II ECG and assessed 4 behaviors, using an analogue scale. Variables were compared among treatment groups by use of a 2-factor ANOVA with data categorized into three 10-day treatment periods. A similar comparison was made among treatment groups with data categorized by time of observation (morning, afternoon, or evening) for all study days. RESULTS: Variables did not differ among groups at study initiation. Pulse rate was the only variable that differed significantly among treatment groups during the study. During the first 10 days of treatment, dogs receiving PPA had a lower pulse rate than dogs that did not. Although signs of illness were apparent in a few dogs, illness did not appear to be related to treatment. CONCLUSIONS AND CLINICAL RELEVANCE: Adverse effects were not detected after administration of selegiline, PPA, or a combination of the drugs in healthy dogs.
Assuntos
Cães/fisiologia , Inibidores da Monoaminoxidase/farmacologia , Fenilpropanolamina/farmacologia , Selegilina/farmacologia , Simpatomiméticos/farmacologia , Animais , Comportamento Animal/efeitos dos fármacos , Pressão Sanguínea/efeitos dos fármacos , Temperatura Corporal/efeitos dos fármacos , Cães/metabolismo , Cães/psicologia , Quimioterapia Combinada , Eletrocardiografia/efeitos dos fármacos , Eletrocardiografia/veterinária , Feminino , Masculino , Pulso Arterial/veterinária , Distribuição Aleatória , Respiração/efeitos dos fármacosRESUMO
OBJECTIVE: To identify complications associated with tibial plateau leveling osteotomy (TPLO) for treatment of cranial cruciate ligament rupture in dogs and assess owner perceptions of outcome. DESIGN: Retrospective study. ANIMALS: 193 dogs that underwent unilateral or bilateral TPLO (253 TPLOs total) between November 1997 and March 2001. PROCEDURE: Complications associated with the surgical procedure were recorded. A questionnaire was sent to owners of all dogs to assess their perceptions of outcome. RESULTS: Complications were identified in 47 of the 193 (24.4%) dogs and in association with 52 of the 253 (20.6%) TPLOs. Dogs that underwent bilateral TPLOs during a single anesthetic episode had a higher complication rate than did dogs that underwent unilateral TPLO and dogs that underwent bilateral TPLOs during separate anesthetic episodes. Body weight, surgery time, whether a meniscal release or meniscectomy was performed, and extent of cruciate ligament damage were not associated with whether complications occurred. One hundred forty-one of 151 (93%) owners who responded to the questionnaire were satisfied with the outcome of the surgery. Assessments of outcome were not significantly different between owners of dogs that had complications and owners of dogs that did not. CONCLUSIONS AND CLINICAL RELEVANCE: Results indicated that complications developed in approximately 25% of dogs undergoing TPLO for treatment of a cranial cruciate ligament injury but that most complications responded to appropriate treatment, and development of complications did not affect owner assessments of outcome. There was a higher incidence of complications when bilateral TPLOs were performed during a single anesthetic episode.
Assuntos
Lesões do Ligamento Cruzado Anterior , Cães/cirurgia , Osteotomia/veterinária , Complicações Pós-Operatórias/veterinária , Tíbia/cirurgia , Animais , Ligamento Cruzado Anterior/cirurgia , Cruzamento , Cães/lesões , Feminino , Fixação Interna de Fraturas/métodos , Fixação Interna de Fraturas/veterinária , Incidência , Masculino , Osteotomia/métodos , Complicações Pós-Operatórias/epidemiologia , Estudos Retrospectivos , Ruptura/cirurgia , Ruptura/veterinária , Resultado do TratamentoRESUMO
A high rate of mortality, expense, and complications of immunosuppressive therapy in dogs underscores the need for optimization of drug dosing. The purpose of this study was to determine, using a flow-cytometric assay, the 50% T-cell inhibitory concentration (IC50) of dexamethasone, cyclosporine, and the active metabolites of azathioprine (6-mercaptopurine) and leflunomide (A77 1726) in canine lymphocytes stimulated with concanavalin A (Con A). Whole blood was collected from 5 privately owned, healthy dogs of various ages, genders, and breeds. Peripheral blood mononuclear cells, obtained by density-gradient separation, were cultured for 72 h with Con A, a fluorochrome-tagged cell proliferation dye, and various concentrations of dexamethasone (0.1, 1, 10, 100, 1000, and 10 000 µM), cyclosporine (0.2, 2, 10, 20, 30, 40, 80, and 200 ng/mL), 6-mercaptopurine (0.5, 2.5, 50, 100, 250, and 500 µM), and A77 1726 (1, 5, 10, 25, 50, and 200 µM). After incubation, the lymphocytes were labeled with propidium iodide and an antibody against canine CD5, a pan T-cell surface marker. Flow cytometry determined the percentage of live, proliferating T-lymphocytes incubated with or without immunosuppressants. The mean (± standard error) IC50 was 3460 ± 1900 µM for dexamethasone, 15.8 ± 2.3 ng/mL for cyclosporine, 1.3 ± 0.4 µM for 6-mercaptopurine, and 55.6 ± 22.0 µM for A77 1722. Inhibition of T-cell proliferation by the 4 immunosuppressants was demonstrated in a concentration-dependent manner, with variability between the dogs. These results represent the initial steps to tailor this assay for individual immunosuppressant protocols for dogs with immune-mediated disease.
Un taux de mortalité élevé, le coût élevé, et les complications associés à la thérapie immunosuppressive chez les chiens font ressortir le besoin d'optimisation de la médication. L'objectif de la présente étude était de déterminer, au moyen d'une épreuve de cytométrie en flux, la concentration de dexaméthazone, de cyclosporine, et des métabolites actifs de l'azathioprine (6-mercaptopurine) et du leflunomide (A77 1726) inhibant 50 % des cellules T (IC50) de lymphocytes canins stimulés avec de la concanavaline A (Con A). Du sang entier fut prélevé de cinq chiens en santé, d'âges, de sexes et de races variés et appartenant à des propriétaires. Des cellules mononucléaires du sang périphérique, obtenues par séparation à l'aide d'un gradient de densité, furent cultivées pendant 72 h avec de la Con A, un colorant de prolifération cellulaire marqué avec un fluorochrome, et diverses concentrations de dexaméthazone (0,1, 1, 10, 100, 1000, et 10 000 µM), de cyclosporine (0,2, 2, 10, 20, 30, 40, 80, et 200 ng/mL), de 6-mercaptopurine (0,5, 2,5, 50, 100, 250, et 500 µM), et de A77 1726 (1, 5, 10, 25, 50, et 200 µM). Après incubation, les lymphocytes furent marqués avec de l'iodure de propidium et un anticorps dirigé contre CD5 canin, un marqueur de surface de toutes les cellules T. La cytométrie en flux a permis de déterminer le pourcentage de lymphocytes T vivants et en prolifération incubés avec ou sans agent immunosuppresseur. La moyenne (± écart-type) de l'IC50 était de 3460 ± 1900 µM pour la dexaméthazone, 15,8 ± 2,3 ng/mL pour la cyclosporine, 1,3 ± 0,4 µM pour la 6-mercaptopurine, et 55,6 ± 22,0 µM pour A77 1722. L'inhibition de la prolifération des cellules T par les quatre agents immunosuppresseurs fut démontrée comme étant dépendante de la concentration, avec une variabilité entre les chiens. Ces résultats représentent les étapes initiales pour adapter cet essai aux protocoles immunosuppresseurs individuels pour les chiens avec des maladies à médiation immunitaire.(Traduit par Docteur Serge Messier).